==== Front Iran J Basic Med Sci Iran J Basic Med Sci IJBMS Iranian Journal of Basic Medical Sciences 2008-3866 2008-3874 Mashhad University of Medical Sciences Mashhad, Iran 10.22038/IJBMS.2023.67669.14820 Original Article Lentinan and β-glucan extract from shiitake mushroom, Lentinula edodes, alleviate acute LPS-induced hematological changes in mice Jafari Mojdeh 1 Boskabaday Mohammad Hossein 2 Rezaee Seyed Abdolrahim 1 Rezaeian Sharareh 3 Behrouz Sepideh 2 Ramezannejad Rezvan 3 Pourianfar Hamid Reza 3* 1 School of Medicine, Mashhad University of Medical Sciences, Inflammation and Inflammatory Diseases Research Centre, Mashhad, Iran 2 Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran 3 Industrial Fungi Biotechnology Research Department, Research Institute for Industrial Biotechnology, Academic Center for Education, Culture and Research (ACECR)- Khorasan Razavi Branch, Mashhad, Iran * Corresponding author: Hamid Reza Pourianfar. Industrial Fungi Biotechnology Research Department, Research Institute for Industrial Biotechnology, Academic Center for Education, Culture, and Research (ACECR)- Khorasan Razavi Branch, Mashhad, Iran. Email: pourianfar@acecr.ac.ir 2023 26 7 836842 4 9 2022 18 3 2023 https://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective(s): Immunomodulatory activity of β-glucans of shiitake mushroom (Lentinula edodes) has been known. We investigated whether β-glucans from L. edodes would attenuate the acute effects of lipopolysaccharides (LPS) on peripheral hematological parameters in mice. Materials and Methods: An in-house β-glucans extract (BG) prepared from fruiting bodies of shiitake mushroom L. edodes was chemically measured and characterized using spectrophotometry and HPLC. Male BALB/c mice directly inhaled aerosolized LPS of 3 mg/ml and were treated with BG or commercial β-glucan (known as lentinan; LNT) (10 mg/kg bw) at 1 hr before or 6 hr after LPS inhalation. The blood samples were collected by cardiac puncture from euthanized mice at 16 hr post-treatment. Results: The results showed a significant reduction in levels of blood parameters, including red blood cells (RBC), hemoglobin (HGB), hematocrit (HCT), and platelets (PLT); and a significant increase in blood lymphocyte counts in LPS-treated mice as compared with the control mice (P≤0.05). Total white blood cells, neutrophils, and monocyte counts did not show any significant difference among the groups. Treatment of LPS-challenged mice with LNT or BG significantly increased the levels of RBC, HGB, HCT, and PLT; and reduced blood lymphocyte counts as compared with LPS-treated mice (P≤0.05). Conclusion: These findings suggest that β-glucans from L. edodes might be effective in attenuating the effects of inhaled LPS on peripheral blood parameters. Thus, these findings might be useful in acute inflammatory diseases particularly pulmonary infectious diseases in which the hematological parameters would be affected. Key Words β-glucans Hematological parameters Inflammation Inhalation Lentinan Lipopolysaccharide Shiitake ==== Body pmcIntroduction Lipopolysaccharide (LPS) also known as endotoxin is the most abundant major component within the gram-negative bacteria cell walls which is involved in the activation of the CD14/TLR4 receptor on the monocytes and macrophages and regulation of the inflammatory cytokines (1). Such inductive effect of LPS has led to the use of this compound in animal models of diseases such as sepsis, mastitis, enteritis, acute lung injury (ALI), and various cancer types (2-6). Administration of LPS in rodent animals is usually carried out using two main routes, including injection (intravenous or intraperitoneal) and pulmonary delivery of LPS (3, 7). The latter can be modeled through either tracheal instillation or inhalation where the alveolar epithelium is the primary damaged structure (8). Pulmonary delivery of LPS may lead to ALI (9), causing infiltration of excessive neutrophils into the lung tissues followed by the release of pro-inflammatory cytokines of endothelial and epithelial lung injury (10). LPS-simulated ALI also increased the content of white blood cells in the lung (11). However, very little is known regarding the effects of pulmonary delivery of LPS on hematological parameters of blood in a murine model. β-glucans are abundant in the cell wall of mushrooms and consist of long or short-chain polymers of glucose subunits with β-1,3 and β-1,6 linkages that are responsible for the linear and branching structures, respectively (12). The most studied health-related effects of mushroom β-glucans include their ability to involve in modulating the immune system (12). Lentinan, a β-glucan with a 1,3 linkage derived from shiitake mushroom (Lentinula edodes) has been widely studied mainly for its immunomodulatory activity. Lentinan triggers signaling pathways, such as MAPK, NF-κB, and Syk-PKC, via binding pattern recognition receptors (TLRs, Dectin-1) and the complement receptor type 3 (CR3, also known as CD11b/CD18) on the membrane of various immune cells particularly natural killers, macrophages, and T cells (13-15). Such effects have also been demonstrated for polysaccharide fractions and extracts containing β-glucans isolated from shiitake mushrooms (14, 16, 17). A number of previous studies have confirmed that lentinan or β-glucans extracts from shiitake mushroom can attenuate in vitro LPS-induced pro-inflammatory cytokines and oxidative stress (17), and improves in vivo LPS-induced mastitis (6), tumor growth (18), and lethality in mice (19). However, no animal study has been undertaken to investigate the alleviative effects of lentinan or β-glucans extracts obtained from shiitake mushrooms in response to LPS delivered through the pulmonary route. Also, very little is known about how lentinan or β-glucans extracts neutralize or ameliorate LPS-induced damages on blood parameters in a murine model. Consequently, the present study aimed to evaluate whether or not a commercial lentinan and an in-house β-glucans extract from shiitake mushroom would attenuate the negative effects of LPS inhaled into the lung on hematological parameters in mice. Materials and Methods Reagents LPS (Escherichia coli, L2630) and Lentinan (S5083) were purchased from Sigma-Aldrich and Selleckchem (USA), respectively. Mushroom and Yeast Beta-glucan kits (K-YBGL 11/19) were purchased from Megazyme (Ireland). Production of in-house polysaccharide extract Fruiting bodies of shiitake mushroom, L. edodes (strain no. M3102, the Mycelia company, Deinze, Belgium) were prepared in the mushroom laboratory of Industrial Fungi Biotechnology Research Department, Academic Center for Education, Culture, and Research (ACECR)-Mashhad, Iran. Mature fruiting bodies were harvested and immediately stored in a -80 °C freezer for 48 hr before being subjected to quick-freezing with liquid nitrogen according to a protocol described previously (20). The frozen samples were transferred to a freeze drier (Ferdowsi University’s central laboratory, Mashhad, Iran) under 0.1 mbar for 72 hr until a fine powder was obtained. The lyophilized samples were stored at -20 °C until use. Polysaccharide extract (PE) of the lyophilized shiitake mushroom was produced based on a hot water method (21, 22). Distilled water with a ratio of 1 to 10 was added to 100 g of the powder and autoclaved for 30 min at 120 °C under the pressure of 1 bar. After cooling, the solution was centrifuged at 10,000 rpm for 10 min. The supernatant was mixed with 96% ethanol and placed at 4 °C for 24 hr. The extract was centrifuged at 10,000 rpm for 10 min. The resultant precipitate considered PE was subjected to freeze-drying as described above. Chemical analysis of β - glucan Quantification of the β-glucan present in the lyophilized PE was performed at 510 nm using a spectrophotometer based on the manufacturer’s instructions of a special mushroom and yeast β-glucan assay kit (cat. No. K-YBGL, Megazyme International, Wicklow, Ireland). In addition, High-performance liquid chromatography (HPLC) analysis of β-glucan was performed using a single four-solvent pump HPLC Model 1100 of Agilent (USA) with a RID detector (Pars Knowledge Pars Company, Isfahan, Iran). The C18 column had a particle size of 4.6 µm in 250 mm and a half-centimeter ODS column. The mobile phase of 100% deionized water with a flow rate of 1 ml/min was isocratically applied with a refractive index detector at ambient temperature. Commercial lentinan was also subjected to HPLC analysis using the same method as described for PE containing β-glucan. The amount of β-glucan in the PE was calculated using the line equation obtained from drawing the standard curve of lentinan (y=156608x-7150.7). Animals Male Balb/C mice (aged 7 weeks, weighing 20 g on average) were provided by the animal housing laboratory of Mashhad University of Medical Sciences (Mashhad, Iran). The experimental protocol for all mice was approved by the Animal Ethics Committee of the Iranian Academic Center for Education, Culture, and Research, Mashhad (code no. IR.ACECR.JDM.REC.1399.010). The animals were kept in a controlled environment with free access to food and water. All mice used in this research were treated humanely according to institutional guidelines for animal welfare, with due consideration to the alleviation of distress and discomfort. LPS preparation and aerosol exposures LPS was freshly reconstituted in 3 mg/ml of phosphate-buffered saline (PBS). The LPS solution was aerosolized with an air nebulizer in the animal housing laboratory of Mashhad University of Medical Sciences (Mashhad, Iran) according to a previous protocol with mice (23), with modifications following a pilot study test. Every five mice were placed in a cylindrical chamber with all output connected to the air nebulizer containing 1.5 ml of the LPS solution. Mice inhaled the aerosolized LPS for 20 min and remained inside the chamber for another 20 min while the air nebulizer was turned off. Control mice were exposed to 1.5 ml of aerosolized PBS under the same condition as described for LPS-treated mice. Preparation of injectable treatment Lentinan or the PE containing β-glucan (20 mg) was reconstituted in 500 μl of 20% (v/v) DMSO in PBS to make a stock of 40 mg/ml. The stock solution was diluted with PBS to reach a concentration of 2 mg/ml, while the concentration of DMSO became equal to 1% v/v. The working solution was filtered through a 0.22-micron filter and placed at 4 °C until use. Then, 100 µl of the cold working solution was used for intraperitoneal injection in each 20-g mouse. This amount of injectable lentinan or the PE containing β-glucan was equal to 10 mg/kg of mouse bw which has been shown to be safe and did not have any negative effect on the survival rate of mice in a previous study (19). Study design Four study groups (n=5 each) were designed as follows: • Control: Mice exposed to aerosolized PBS and euthanized after 16 hr. • Sham: Mice exposed to aerosolized LPS (dose: 3 mg/ml in PBS; 1.5 ml final volume) and euthanized after 16 hr. These mice were treated with PBS alone. • LPSLNT: Mice treated with lentinan (10 mg/kg bw) at 6 hr after (treatment) or 1 hr before (prophylaxis) exposure to aerosolized LPS (dose: 3 mg/ml in PBS; 1.5 ml final volume). Mice were euthanized 16 hr after exposure to LPS. • LPSBG: Mice treated with the PE containing β-glucan (10 mg/kg bw) at 6 hr after (treatment) or 1 hr before (prophylaxis) exposure to aerosolized LPS (dose: 3 mg/ml in PBS; 1.5 ml final volume). Mice were euthanized 16 hr after exposure to LPS. Blood collection Mice were deeply anesthetized by 100 µl of a mixture of 10% xylazine and 10% ketamine at the ratio of 3:7. The blood samples were obtained by cardiac puncture. In brief, the anterior abdominal wall was split and then the diaphragm muscle was removed. The beating heart was gently accessed and cardiac blood was extracted by a 22G needle from the right and left ventricles. About 500 µl of the blood was poured into EDTA-treated tubes and kept shaking to avoid agglutination until they were subjected to cytometry. A complete blood count (CBC) of the blood samples was done by a Hematology Analyzer (Siemens, ADVIA® 2120i) in the medical central laboratory of the Iranian Academic Center for Education, Culture, and Research (ACECR), Mashhad, Iran. Table 1 shows the hematological parameters measured by the Hematology Analyzer. Statistical analysis Data were subjected to one-way ANOVA using SPSS software version 25. Mean values were compared by Duncan’s Multiple Range Test and reported as means±standard deviation. A probability of P≤0.05 was considered to be significant. Graph prism version 9 was utilized to draw graphs. Results Confirmation of β - glucans in the in-house extract The extraction efficiency of PE was found to be 9.12% of the shiitake mushroom powder (dw). The mushroom and yeast β-glucan assay kit-based quantification of glucans showed that PE contained 27% β-glucan and 5% α-glucan. Further HPLC analysis revealed that PE produced a clear and strong peak with a retention time (RT) of 4.748 min (Figure 1a). A similar peak with an RT of 4.786 was also obtained with LNT (Figure 1b) as a nearly pure β-glucan extracted from shiitake mushroom. According to the peak area quantification, PE contained 27.5% β-glucan (dw) which confirmed the kit-based findings. RBC, hematocrit, and MCV contents As depicted in Figure 2, inhalation of LPS by healthy mice significantly reduced their RBC amount compared with the control group (P≤0.05). LPS-exposed mice treated with LNT or BG displayed a significantly higher level of RBC compared with the sham group (P≤0.05). In addition, there was no statistically significant difference in RBC levels between the control and LPS-exposed mice treated with LNT, with RBC levels in each of these groups being 8.8 and 8.6 million/μl, respectively (P≥0.05). However, the RBC content in LPS-exposed mice treated with BG was significantly lower than in the control mice (P≤0.05). The prophylactic groups of mice exhibited different results as compared with the treatment groups. Pre-treatment of mice with LNT or BG did not compensate for the decrease in RBC count caused by LPS inhalation compared with the control mice (Figure 2). As expected from the results of the RBC count, inhalation of LPS by healthy mice significantly reduced their hematocrit levels compared with the control group (P≤0.05) (Figure 3). The hematocrit content of 40.6% in the LPS-exposed mice treated with PBS was significantly lower than that of LPS-exposed mice treated with LNT (P≤0.05). However, the hematocrit content of neither LNT nor BG groups reached that of the control group (P≤0.05). In the prophylaxis tests, no alleviative effect of LNT or BG was observed in the LPS-challenged mice as compared with the control group (Figure 3). The average size of RBC indicated as mean corpuscular volume (MCV) decreased in LPS-exposed mice, but this reduction was not significant (P≥0.05). Although treatment of LPS-exposed mice with LNT or BG apparently increased MCV, the difference was not statistically significant at P-value less than 0.05 (Figure 4). Meanwhile, pre-treatment of mice with BG in the prophylactic groups caused a reduction in MCV as compared with the sham group (Figure 4). Hemoglobin and MCHC contents Hemoglobin (HGB) levels of healthy mice exposed to LPS inhalation were notably lower than the control group (P≤0.05). Although treatment of LPS-exposed mice with LNT increased their HGB levels, only BG significantly increased the HGB content of LPS-challenged mice from 11.18 to 12.14 g/dL (P≤0.05). However, neither LNT nor BG reaches the count of hemoglobin in the control group statistically (P≤0.05). Similar to the RBC count, Pre-treatment of mice with LNT or BG did not significantly alleviate the reducing effect of LPS inhalation on mice hemoglobin levels (Figure 5). The mean corpuscular hemoglobin concentration (MCHC) measures the average concentration of HGB in the RBCs. The findings showed a significant increase in MCHC following LPS inhalation in mice. Treatment with LNT was able to significantly reduce this index to the control group level. In the prophylaxis group, no significant difference in the level of MCHC was observed between the sham and the treatment groups (Figure 6). Platelet and MPV contents Inhalation of LPS by healthy mice considerably reduced their platelet levels compared with the control group (P≤0.05). Post-treatment or pre-treatment of LPS-exposed mice with LNT or BG significantly increased the platelet levels as compared with the sham group (P≤0.05). However, no treatment could increase this index as much as that of the control group (Figure 7). Despite changes in the number of platelets, there was no statistically significant change in the average size of platelets indicated as mean platelet volume (MPV) among the groups (Figure 8). Cardiac WBC and differential count Healthy mice receiving LPS by inhalation showed a significant increase in their cardiac lymphocyte counts compared with the control group (P≤0.05) (Table 2). In contrast, lymphocytes reduced to the levels observed in the control group after treatment of LPS-exposed mice with LNT or BG (Table 2). Cardiac total WBC, neutrophils, and monocytes did not show any significant changes between the treatment groups. Pre-treatment of mice with LNT or BG decreased the counts of neutrophils and lymphocytes as compared with the sham group. However, no change in monocyte levels was observed in the prophylaxis groups (Table 2). Discussion In this study, we used a murine model with direct inhalation of aerosolized LPS in order to assess its acute effects on peripheral blood parameters. Then, LPS-challenged mice were treated with a β-glucan extract directly obtained from fruiting bodies of shiitake mushrooms and a nearly purified commercially available β-glucan (known as Lentinan) derived from the same mushroom species. Overall, our findings for the first time revealed that pulmonary delivery of aerosolized LPS apparently decreased the levels of RBC, HGB, and HCT in the peripheral blood of mice. These results are in agreement with the findings obtained from intraperitoneal injection of LPS where a significant decline was observed in several peripheral blood parameters including RBC, HGB, HCT, MCHC, and PLT in mice (24). Recently it was also shown that injected LPS decreased cardiac RBC content in mice (5). In addition, RBC aggregation and deformability were also observed in 24 hr after IP injection of LPS in mice (25). Similar findings have also been obtained with rats where IP injection of LPS declined peripheral HGB (26, 27). This study also showed a decline in peripheral blood PLTs 16 hr after inhalation of LPS in mice. These findings are in perfect match with previous studies, where a rapid reduction in the number of circulating platelets occurred at 3 hr to 24 hr post-LPS injection in the peripheral blood of mice and rats (24, 26, 28-34). PLTs are non-nucleate blood cells with reported roles in hemostasis and immune responses by interacting with other cells of the immune system and by secreting inflammatory mediators (35). Therefore, PLT has been known as an important agent in inflammatory reactions, particularly in acute form. Since TLR4 is also expressed on the surface of PLTs, they possess a functional receptor for bacterial LPS-inducing inflammation (34). It has also been demonstrated that the effect of LPS on blood PLT levels depends on the time elapsed after LPS injection, so PLT depletion at early hours post-LPS injection has been shown to prevent LPS-induced rapid shock but also increase delayed lethality (34). Consistently with animal-based findings, increased mortality of septic patients has clinically been associated to reduce numbers of circulating PLTs (36). Taken together, the findings of the present study may suggest that direct inhalation of aerosolized LPS would have acute effects on peripheral blood parameters in mice in the same way as intraperitoneal or intravenous injection of LPS. This study also showed a considerable increase in total peripheral blood lymphocyte counts and no significant change in the levels of total WBC, neutrophils, and monocytes in response to pulmonary delivery of LPS in mice. These findings may contradict a previous work in which total WBC levels obtained from the blood of mice showed a marked increase at 4 hr after injection of LPS followed by a decrease during 12 hr (37). Contrarily, another study reported that the WBC count declined significantly at 3 hr after LPS injection and increased with time showing a partial normalization at 12 hr in rats and mice (31). Thus, the changes in the levels of total WBC and its differential cells in response to LPS observed in this study might be related to a specific inflammation pattern of these cells 16 hr after LPS inhalation, which could be different from the outcome of LPS injection. However, the result obtained from some studies showed that LPS is T cell-independent B cell mitogen and polyclonal activator in mice. Mitogens are substances that cause DNA synthesis, blast transformation, and ultimately the division of lymphocytes (38). According to the current study, mice given shiitake-derived β-glucans (BG or LNT) after being exposed to aerosolized LPS had significantly higher levels of RBC, HGB, and PLT and lower levels of lymphocytes in their peripheral blood. These findings might be confirmed by previous observations that bacterial BG significantly increased the WBC count, RBC count, HCT, HGB, and PLT in males fed BG than in control rats (39). LNT is an immune activator that activates macrophages and lymphocytes, increases the chemotaxis of macrophages and the toxic response of lymphocytes to Yac-1 cells and P-815 cells, and antagonizes the carcinogenicity of BBN in mice (40). To the best of our knowledge, this is the first in vivo study to report the relieving effects of mushroom-derived β-glucans in relation to the hematological effects of LPS, although its immunomodulatory effects have been well understood in vitro (14, 16, 17) and in vivo (4, 6, 18, 19, 41, 42). Table 1 Measured hematological parameters in peripheral blood of mice challenged with LPS in this study Hematological parameters No. Complete name Abbreviation Unit 1 Red Blood Cell RBC Mil/μl 2 Mean Corpuscular Volume MCV fL 3 Hematocrit HCT % 4 Hemoglobin HGB g/dl 5 Mean Corpuscular Hemoglobin Concentration MCHC g/dl 6 Platelet PLT Tho/μl 7 Mean Platelet Volume MPV fL 8 White Blood Cell WBC count 9 Lymphocyte - count 10 Monocyte - count 11 Neutrophil - count Figure 1 HPLC chromatogram of commercially available nearly pure lentinan and a polysaccharide extract containing β-glucan isolated from fruiting bodies of shiitake mushroom Figure 2 Effects of β-glucans from shiitake mushroom on improving red blood cell (RBC) levels in peripheral blood of mice challenged with LPS Values are expressed as means±standard deviation generated from five mice in each group LNT: Lentinan; BG: Polysaccharide extract containing β-glucans Figure 3 Effects of β-glucans from shiitake mushroom on changes in hematocrit percentages in peripheral blood of mice challenged with LPS Values are expressed as means±standard deviation generated from five mice in each group LNT: Lentinan; BG: polysaccharide extract containing β-glucans Figure 4 Effects of β-glucans from shiitake mushroom on improving mean corpuscular volume (MCV) levels in peripheral blood of mice challenged with LPS Values are expressed as means±standard deviation generated from five mice in each group LNT: Lentinan; BG: Polysaccharide extract containing β-glucans Figure 5 Effects of β-glucans from shiitake mushroom on improving hemoglobin levels in peripheral blood of mice challenged with LPS Values are expressed as means±standard deviation generated from five mice in each group LNT: Lentinan; BG: Polysaccharide extract containing β-glucans Figure 6 Effects of β-glucans from shiitake mushroom on improving mean corpuscular hemoglobin concentration (MCHC) levels in peripheral blood of mice challenged with LPS Values are expressed as means±standard deviation generated from five mice in each group LNT: Lentinan; BG: Polysaccharide extract containing β-glucans Figure 7 Effects of β-glucans from shiitake mushrooms on improving platelet contents in peripheral blood of mice challenged with LPS Values are expressed as means±standard deviation generated from five mice in each group LNT: Lentinan; BG: Polysaccharide extract containing β-glucans Figure 8 Effects of β-glucans from shiitake mushrooms on improving mean platelet volume (MPV) levels in peripheral blood of mice challenged with LPS Values are expressed as means±standard deviation generated from five mice in each group LNT: Lentinan; BG: Polysaccharide extract containing β-glucans Table 2 Effects of β-glucans from shiitake mushroom on improving total WBC and differential count in peripheral blood of mice challenged with LPS (n=5 each) Control LPS+PBS LPS LNT LPS BG Control LPS+PBS LPS LNT LPS BG Total WBC 2200a 2683a 1806a 2220a 2200a 2683a 2000a 1640a Neutrophil 130a 188a 120a 158a 130b 188a 88.33b 58.00b Lymphocyte 1082b 2042a 834b 1145b 1082b 2042a 630b 535b Monocyte 704a 604a 492a 571a 704a 604a 735a 703a Values shown are the means of five mice±standard deviation of the mean. In each row, the statistical lower-case letters including “a, b” indicate significant differences between the means at the statistical level of 5% or less (P≤0.05). Values followed by the same lower-case letters are not significantly different LNT: Lentinan; BG: Polysaccharide extract containing β-glucans Conclusion The evidence from this study for the first time demonstrates that β-glucans from shitake mushroom, L. edodes, may be effective in attenuating the effects of inhaled aerosolized LPS on blood parameters. These findings might be used for further research mimicking characteristics of diseases caused by aerosol or air-borne transmission of infectious microorganisms in which hematological parameters would be affected. Authors’ Contributions MJ performed in vivo experiments, MHB discussed the results and strategy, SA RR discussed the results and strategy, SH R performed in vitro experiments, SB performed in vivo experiments, RR performed in vivo experiments and collected data, HP supervised and managed the study, performed in vivo experiments, and wrote the manuscript. Conflicts of Interest The authors declare that they have no conflicts of interest. Acknowledgment This study was conducted as part of a research project financed by the Iranian Biotechnology Development Headquarters, Iran (code no.: biodc 31957-33143.1) granted to HR Pourianfar. ==== Refs References 1 Tawfik DM Lankelma JM Vachot L Cerrato E Pachot A Wiersinga WJ Comparison of host immune responses to LPS in human using an immune profiling panel, in vivo endotoxemia versus ex vivo stimulation Sci Rep 2020 10 1 10 31913322 2 Jain N Shahal T Gabrieli T Gilat N Torchinsky D Michaeli Y Global modulation in DNA epigenetics during pro-inflammatory macrophage activation Epigenetics 2019 14 1183 1193 31262215 3 Domscheit H Hegeman MA Carvalho N Spieth PM Molecular dynamics of lipopolysaccharide-induced lung injury in rodents Front Physiol 2020 5 11 36 4 Lv H Liu Q Sun Y Yi X Wei X Liu W Zhang Q Yi H Chen G Mesenchymal stromal cells ameliorate acute lung injury induced by LPS mainly through stanniocalcin-2 mediating macrophage polarization Ann Transl Med 2020 8 1 15 32055592 5 Ali H Khan A Ali J Ullah H Khan A Ali H Irshad N Khan S Attenuation of LPS-induced acute lung injury by continentalic acid in rodents through inhibition of inflammatory mediators correlates with increased Nrf2 protein expression BMC Pharmacol Toxicol 2020 21 1 4 31900240 6 Urbano M Eljso C Catarina G Hematological changes in SARS-COV-2 positive patients ABHH 2022 44 218 224 7 dos Santos Gomes FO Oliveira AC Ribeiro EL da Silva BS Dos Santos LA de Lima IT Intraurethral injection with LPS: An effective experimental model of prostatic inflammation Inflamm Res 2018 67 43 55 29151155 8 Menezes SL Bozza PT Faria Neto HC Laranjeira AP Negri EM Capelozzi VL Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses J Appl Physiol 2005 98 1777 1783 15649870 9 Guo JM Xing HJ Cai JZ Zhang HF Xu SW H2S exposure-induced oxidative stress promotes LPS-mediated hepatocyte autophagy through the PI3K/AKT/TOR pathway Ecotoxicol Environ Saf 2021 209 111801 111807 33383342 10 Han AA Currie HN Loos MS Scardoni G Miller JV Prince N The impact of cytokine responses in the intra-and extracellular signaling network of a traumatic injury Cytokine 2018 106 136 147 29103821 11 Costola-de-Souza C Ribeiro A Ferraz-de-Paula V Calefi AS Aloia TP Gimenes-Júnior JA Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice PloS One 2013 8 e77706 77720 24204926 12 Cerletti C Esposito S Iacoviello L Edible mushrooms and beta-glucans: Impact on human health Nutrients 2021 13 2195 2207 34202377 13 Zhang M Kim JA Huang AY Optimizing tumor microenvironment for cancer immunotherapy: β-glucan-based nanoparticles Front Immunol 2018 9 341 354 29535722 14 Chen M Fan B Liu S Imam KM Xie Y Wen B Xin F The in vitro effect of fibers with different degrees of polymerization on human gut bacteria Front Microbiol 2020 11 819 830 32477290 15 Mirończuk-Chodakowska I Kujawowicz K Witkowska AM Beta-Glucans from Fungi: Biological and Health-Promoting Potential in the COVID-19 Pandemic Era Nutrients 2021 13 3960 3982 34836215 16 Morales D Rutckeviski R Villalva M Abreu H Soler-Rivas C Santoyo S Isolation and comparison of α-and β-D-glucans from shiitake mushrooms (Lentinula edodes) with different biological activities Carbohydr Polym 2020 229 115521 115532 31826486 17 Murphy EJ Masterson C Rezoagli E O’Toole D Major I Stack GD β-Glucan extracts from the same edible shiitake mushroom Lentinus edodes produce differential in vitro immunomodulatory and pulmonary cytoprotective effects Implications for coronavirus disease (COVID-19) immunotherapies Sci Total Environ 2020 732 139330 139339 32413619 18 Moriya N Miwa H Orita K Antitumor effects of bacterial lipopolysaccharide and tumor necrosis factor in mice Jpn J Surg 1984 14 163 166 6379248 19 Ahn E Lee J Jeon YH Choi SW Kim E Anti-diabetic effects of mulberry (Morus alba L ) branches and oxyresveratrol in streptozotocin-induced diabetic mice Food Sci Biotechnol 2017 26 1693 1702 30263707 20 Mohammadnejad S Pourianfar HR Drakhshan A Jabaleh I Rezayi M Potent antiproliferative and pro-apoptotic effects of a soluble protein fraction from culinary-medicinal mushroom Lentinus tigrinus on cancer cells J Food Meas Charact 2019 13 3015 3024 21 Avni S Ezove N Hanani H Yadid I Karpovsky M Hayby H Olive mill waste enhances α-glucan content in the edible mushroom Pleurotus eryngii Int J Mol Sci 2017 18 1564 1574 28718825 22 Gover O Hayby H Levy A Fishman E Danay O Ezov N Enhanced anti-inflammatory effects by glucans extracted from the stalks of Pleurotus eryngii grown in substrates containing olive mill waste JNHFS 2019 2372 0980 23 Zeinali H Baluchnejadmojarad T Roghani M Effect of oral administration of s-allyl cysteine (the active ingredient in the aged garlic extract) on the symptoms of multiple sclerosis in the experimental model Qom Univ Med Sci J 2020 14 76 84 24 Li C Zhang WJ Frei B Quercetin inhibits LPS-induced adhesion molecule expression and oxidant production in human aortic endothelial cells by p38-mediated Nrf2 activation and antioxidant enzyme induction Redox Biol 2016 9 104 113 27454768 25 Myung J Park SJ Lim J Kim YH Shin S Lim CH Effects of lipopolysaccharide on changes in red blood cells in a mice endotoxemia model Clin Hemorheol Microcirc 2016 63 305 312 26484719 26 Al-Sagair OA El-Daly ES Mousa AA Influence of bacterial endotoxins on bone marrow and blood components Med J Islamic World Acad Sci 2009 17 23 36 27 Zhong Y Zhang X Hu X Li Y Effects of repeated lipopolysaccharide treatment on growth performance, immune organ index, and blood parameters of Sprague-Dawley rats J Vet Res 2018 62 341 346 30584614 28 Zhao L Ohtaki Y Yamaguchi K Matsushita M Fujita T Yokochi T LPS-induced platelet response and rapid shock in mice: contribution of O-antigen region of LPS and involvement of the lectin pathway of the complement system Am J Hematol 2002 100 3233 3239 29 Yu LC Flynn AN Turner JR Buret AG SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS‐induced apoptosis and barrier defects: A novel cellular rescue mechanism? FASEB J. 2005 19 1822 1835 16260652 30 Wu D Xie J Wang X Zou B Yu Y Jing T Micro-concentration lipopolysaccharide as a novel stimulator of megakaryocytopoiesis that synergizes with IL-6 for platelet production Sci Rep 2015 5 1 6 31 Steven S Dib M Roohani S Kashani F Münzel T Daiber A Time response of oxidative/nitrosative stress and inflammation in LPS-induced endotoxaemia a comparative study of mice and rats Int J Mol Sci 2017 18 2176 2187 29057830 32 Niu S Paluszynski J Bian Z Shi L Kidder K Liu Y LPS-primed CD11b+ leukocytes serve as an effective carrier of Shiga toxin 2 to cause hemolytic uremic syndrome in mice Sci Rep 2018 8 3994 31004 29507316 33 Tariket S Guerrero JA Garraud O Ghevaert C Cognasse F Platelet α-granules modulate the inflammatory response under systemic lipopolysaccharide injection in mice Transfusion 2019 59 32 38 30394544 34 Martyanov AA Maiorov AS Filkova AA Ryabykh AA Svidelskaya GS Artemenko EO Effects of bacterial lipopolysaccharides on platelet function: Inhibition of weak platelet activation Sci Rep 2020 10 1 10 31913322 35 Liverani E Lung injury during LPS-induced inflammation occurs independently of the receptor P2Y1 Purinergic Signal 2017 13 119 125 27815804 36 Tridente A Clarke GM Walden A Gordon AC Hutton P Chiche JD Association between trends in clinical variables and outcome in intensive care patients with faecal peritonitis: Analysis of the GenOSept cohort Crit care 2015 19 1 10 25560635 37 Jafari O Babaei H Kheirandish R Samimi AS Zahmatkesh A Histomorphometric evaluation of mice testicular tissue following short-and long-term effects of lipopolysaccharide-induced endotoxemia Iran J Basic Med Sci 2018 21 47 52 29372036 38 Dziarski RO Studies on the mechanism of peptiglycan and lipopolysaccharide-induced polyclonal activation Infect Immun 1982 35 507 514 6460001 39 Chang ZQ Reza MA Lee JS Gebru E Jang SH Choi MJ Immunomodulatory activities and subacute toxicity of a novel β-glucan from Paenibacillus polymyxa JB115 in rats Immunopharmacol Immunotoxicol 2011 33 124 134 20500124 40 Kurashige S Akuzawa Y Endo F Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine Immunopharmacol Immunotoxicol 1997 19 175 183 9130004 41 Djordjevic B Škugor S Jørgensen SM Øverland M Mydland LT Krasnov A Modulation of splenic immune responses to bacterial lipopolysaccharide in rainbow trout (Oncorhynchus mykiss) fed lentinan, a beta-glucan from mushroom Lentinula edodes Fish Shellfish Immunol 2009 26 201 209 19010422 42 Ren J Li L Wang Y Zhai J Chen G Hu K Gambogic acid induces heme oxygenase-1 through Nrf2 signaling pathway and inhibits NF-κB and MAPK activation to reduce inflammation in LPS-activated RAW264 7 cells Biomed Pharmacother 2019 109 555 562 30399591